TrialCancer chemotherapy and pharmacology2016

Comparative pharmacokinetics, safety, and tolerability of two sources of ch14.18 in pediatric patients with high-risk neuroblastoma following myeloablative therapy.

Araz Marachelian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.